Vera Petrova
Overview
Explore the profile of Vera Petrova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petrova V, Groth C, Bitsch R, Arkhypov I, Simon S, Hetjens S, et al.
Front Immunol
. 2023 Mar;
14:1065767.
PMID: 36860876
Purpose: Although the treatment of advanced melanoma patients with immune checkpoint inhibitors (ICI) significantly increased the therapeutic efficiency, many patients remain resistant to ICI that could be due to immunosuppression...
2.
Arkhypov I, Ozbay Kurt F, Bitsch R, Novak D, Petrova V, Lasser S, et al.
J Immunother Cancer
. 2022 Sep;
10(9).
PMID: 36113897
Background: Tumor cells modulate host immunity by secreting extracellular vesicles (EV) and soluble factors. Their interactions with myeloid cells lead to the generation of myeloid-derived suppressor cells (MDSC), which inhibit...
3.
Groth C, Weber R, Lasser S, Ozbay F, Kurzay A, Petrova V, et al.
Int J Cancer
. 2021 Jul;
149(9):1628-1638.
PMID: 34224592
Myeloid-derived suppressor cells (MDSC) represent a highly immunosuppressive population that expands in tumor bearing hosts and inhibits both T and NK cell antitumor effector functions. Among MDSC subpopulations, the polymorphonuclear...
4.
Groth C, Arpinati L, Shaul M, Winkler N, Diester K, Gengenbacher N, et al.
Cancers (Basel)
. 2021 Feb;
13(4).
PMID: 33578808
Background: Despite recent improvement in the treatment of malignant melanoma by immune-checkpoint inhibitors, the disease can progress due to an immunosuppressive tumor microenvironment (TME) mainly represented by myeloid-derived suppressor cells...
5.
Weber R, Groth C, Lasser S, Arkhypov I, Petrova V, Altevogt P, et al.
Cell Immunol
. 2020 Dec;
359:104254.
PMID: 33296753
Myeloid-derived suppressor cells (MDSC) are generated during tumor progression and suppress the anti-tumor functions of T and natural killer (NK) cells. Their enrichment is associated with a bad prognosis and...
6.
Arkhypov I, Lasser S, Petrova V, Weber R, Groth C, Utikal J, et al.
Int J Mol Sci
. 2020 Sep;
21(17).
PMID: 32878277
Extracellular vesicles (EV) can carry proteins, RNA and DNA, thus serving as communication tools between cells. Tumor cells secrete EV, which can be taken up by surrounding cells in the...
7.
Sarria G, Petrova V, Wenz F, Abo-Madyan Y, Sperk E, Giordano F
Radiat Oncol
. 2020 May;
15(1):110.
PMID: 32410696
Background: Soft tissue sarcomas (STS) treatment remains a therapeutic challenge. Intraoperative radiotherapy (IORT) resembles a safe and efficient for STS treatment. The first data on electronic-IORT (eIORT) using low-energy photons...
8.
Petrova V, Arkhypov I, Weber R, Groth C, Altevogt P, Utikal J, et al.
Int J Mol Sci
. 2020 Apr;
21(7).
PMID: 32235439
Although melanoma is one of the most immunogenic tumors, it has an ability to evade anti-tumor immune responses by exploiting tolerance mechanisms, including negative immune checkpoint molecules. The most extensively...
9.
Kathijotes N, Zlatareva E, Marinova S, Petrova V
Water Sci Technol
. 2016 Sep;
74(6):1499-1508.
PMID: 27685979
The aim of this study is to establish changes that may occur after a prolonged application of wastewater sludge treated to biosolids, in the 'soil-fertilizer-plant' system. Thirteen experimental plots with...
10.
Boitsov S, Petrova V, Jensen H, Kursheva A, Litvinenko I, Klungsoyr J
Mar Environ Res
. 2013 Apr;
87-88:73-84.
PMID: 23623160
Variability in levels and sources of polycyclic aromatic hydrocarbons (PAH) in sediments from one large sea area off the coast of northern Norway ("North area", NA) have been compared to...